Pharma industry warns lawmakers not to dilute Critical Medicines Act

EU PERSPECTIVES - Last week, the European Parliament's health committee adopted its report on the Critical Medicines Act (CMA). The measure passed with 27 votes in favour, one against and eight abstentions. But while MEP's hail it as a breakthrough, the pharma industry says the plan risks drifting away from its original goal. Read more

Patient-centric, or diluted? / Photo: Unsplash